CARLOMAGNO, FRANCESCA
CARLOMAGNO, FRANCESCA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Molecular mechanisms of RET activation in human cancer
2002 Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity.
1999 Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).
2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
The extent of linkage disequilibrium in four populations with distinct demographic histories
2000 Dunning, Am; Durocher, F; Healey, Cs; Teare, Md; Mcbride, Se; Carlomagno, Francesca; Xu, Cf; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, Rn; VAN RENSBURG, Ej; Mannermaa, A; Kataja, V; Rennart, G; Dunhami, ; Purvis, I; Easton, D; Ponder, Ba
NCOA4 inhibits initiation of DNA replication to maintain genome stability
2012 Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Oncogenic rearrangements driving ionizing radiation-associated human cancer
2013 Santoro, Massimo; Carlomagno, Francesca
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma
2002 F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo
Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage
2007 M., Allocca; U., Di Vicino; M., Petrillo; F., Carlomagno; L., Domenici; Auricchio, Alberto; Carlomagno, Francesca
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
2000 De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Ret-mediated mitogenesis requires Src kinase activity.
1999 Melillo, R. M.; Barone, M. V.; Lupoli, Gelsy; Cirafici, A. M.; Carlomagno, F.; Visconti, Roberta; Matoskova, B.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, A.; Santoro, M.
Different mutations of the RET gene cause different human tumoral diseases.
1999 Santoro, M.; Melillo, R. M.; Carlomagno, F.; Visconti, Roberta; DE VITA, Gabriella; Salvatore, Giuliana; Fusco, A.; Vecchio, Giancarlo
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease
1998 Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
Molecular heterogeneity of RET loss of function in Hirschsprung's disease.
1996 Carlomagno, F; De Vita, G; Berlingieri, Mt; De Franciscis, V; Melillo, Rosa Marina; Colantuoni, V; Kraus, Mh; Di Fiore, Pp; Fusco, Alfredo; M., Santoro
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret
1998 Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, Rosa Marina; Bucci, C; De Franciscis, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M.
Molecular targeting of the RET kinase in thyroid cancer
2007 Santoro, Massimo; Carlomagno, F.
Molecular Mechianism of RET Activation In Human Neoplasia
2002 Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer
2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati
2009 Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi.
2007 Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo
Pros and cons of cellular studies in developing new drugs for thyroid cancers
2008 Salvatore, G.; Carlomagno, Francesca; Santoro, Massimo
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Molecular mechanisms of RET activation in human cancer | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo | |
| Ret-mediated mitogenesis requires Src kinase activity. | 1.1 Articolo in rivista | 1999 | Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo | |
| Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). | 1.1 Articolo in rivista | 2003 | Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo | |
| The extent of linkage disequilibrium in four populations with distinct demographic histories | 1.1 Articolo in rivista | 2000 | Dunning, Am; Durocher, F; Healey, Cs; Teare, Md; Mcbride, Se; Carlomagno, Francesca; Xu, Cf; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, Rn; VAN RENSBURG, Ej; Mannermaa, A; Kataja, V; Rennart, G; Dunhami, ; Purvis, I; Easton, D; Ponder, Ba | |
| NCOA4 inhibits initiation of DNA replication to maintain genome stability | 4.2 Abstract in Atti di convegno | 2012 | Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca | |
| Oncogenic rearrangements driving ionizing radiation-associated human cancer | 1.1 Articolo in rivista | 2013 | Santoro, Massimo; Carlomagno, Francesca | |
| Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma | 1.1 Articolo in rivista | 2002 | F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo | |
| Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage | 1.1 Articolo in rivista | 2007 | M., Allocca; U., Di Vicino; M., Petrillo; F., Carlomagno; L., Domenici; Auricchio, Alberto; Carlomagno, Francesca | |
| Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival | 1.1 Articolo in rivista | 2000 | De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M. | |
| Ret-mediated mitogenesis requires Src kinase activity. | 1.1 Articolo in rivista | 1999 | Melillo, R. M.; Barone, M. V.; Lupoli, Gelsy; Cirafici, A. M.; Carlomagno, F.; Visconti, Roberta; Matoskova, B.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, A.; Santoro, M. | |
| Different mutations of the RET gene cause different human tumoral diseases. | 1.1 Articolo in rivista | 1999 | Santoro, M.; Melillo, R. M.; Carlomagno, F.; Visconti, Roberta; DE VITA, Gabriella; Salvatore, Giuliana; Fusco, A.; Vecchio, Giancarlo | |
| Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease | 1.1 Articolo in rivista | 1998 | Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M. | |
| Molecular heterogeneity of RET loss of function in Hirschsprung's disease. | 1.1 Articolo in rivista | 1996 | Carlomagno, F; De Vita, G; Berlingieri, Mt; De Franciscis, V; Melillo, Rosa Marina; Colantuoni, V; Kraus, Mh; Di Fiore, Pp; Fusco, Alfredo; M., Santoro | |
| Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret | 1.1 Articolo in rivista | 1998 | Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, Rosa Marina; Bucci, C; De Franciscis, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M. | |
| Molecular targeting of the RET kinase in thyroid cancer | 8.02 Comunicazioni a Convegni o Seminari | 2007 | Santoro, Massimo; Carlomagno, F. | |
| Molecular Mechianism of RET Activation In Human Neoplasia | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo | |
| Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer | 4.2 Abstract in Atti di convegno | 2012 | Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA | |
| I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati | 3.1 Monografia o trattato scientifico | 2009 | Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo | |
| Basi molecolari delle nuove terapie: inibitori delle protein-chinasi. | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo | |
| Pros and cons of cellular studies in developing new drugs for thyroid cancers | 1.1 Articolo in rivista | 2008 | Salvatore, G.; Carlomagno, Francesca; Santoro, Massimo |